Navigation Links
Wellcome-Wolfson partnership makes £30 million investment in UK scientific infrastructure
Date:7/2/2010

Over 30 million is being invested into large-scale university infrastructure projects courtesy of the Wellcome-Wolfson Capital Awards initiative.

The scheme is intended to facilitate internationally competitive, leading-edge biomedical research in a way that would not otherwise be possible. The projects that have been funded include both new buildings and refurbishment.

The biennial Capital Awards initiative was launched in 2007 to follow the successful Joint Infrastructure and Science Research Innovation Fund partnerships. It provides funding to successful applicants for large scale projects in partnership with the host institution.

This year, the Wellcome Trust and the Wolfson Foundation are working in partnership to fund the initiative. Together, the two charities are providing over 30 million of investment in UK research infrastructure. Under the initiative, universities from across the UK, including three in Scotland, have been awarded funding of between 3-5 million.

"World-class science needs to be supported by world-class infrastructure, which requires significant investment," says Sir Mark Walport, Director of the Wellcome Trust. "The Capital Awards partnership between the Wellcome Trust and the Wolfson Foundation will provide an important injection of cash into our universities at a time when they face uncertainty about future capital funding."

"The programme attracted a strikingly high standard of applications and we are delighted to be funding such exceptional projects," says Paul Ramsbottom, Chief Executive of the Wolfson Foundation. "It is also a great pleasure to be working again with the Wellcome Trust, and the partnership is of particular importance when universities are facing challenging financial circumstances."

Professor Simon Duckett at University of York is one of the recipients of the Capital Awards, having secured 4.36 million for the York Centre for Hyperpolarisation in MRI. Hyperpolarisation enables imaging measurements to be made in a few seconds that were previously impossible and the Centre's 10-year programme of inter-disciplinary work will turn this important scientific discovery into specific clinical applications.

"We expect this Wellcome-Wolfson grant to provide the stepping stone necessary to take a very exciting new magnetic resonance imaging technology forward which we hope will become significant in the rapid screening of a wide range of diseases," says Professor Duckett. "This grant will help provide a dedicated building that will bring together the equipment, laboratory facilities and the multidisciplinary research team needed to achieve this goal."

The full list of recipients, including in-principle awards, is:

  • Principal Investigators: Professor Colin Ingram, Newcastle University
    Award: 4.88 million
    Project title: Centre for Translational Systems Neuroscience

  • Principal Investigator: Professor Alan Stitt, Queen's University Belfast
    Award: 4.80 million
    Project title: Development of a Vision Science Research Building

  • Principal Investigator: Professor Andrew Hattersley, Peninsula College of Medicine, Exeter & Plymouth Universities
    Award: 4.75 million
    Project title: Centre for Translational Medicine in Exeter

  • Principal Investigator: Professor Mike Ferguson, University of Dundee
    Award: 4.88 million
    Project title: Centre for Translational and Interdisciplinary Research

  • Principal Investigator: Professor David Porteous, University of Edinburgh
    Award: 3.46 million
    Project title: Institute of Genetics & Molecular Medicine

  • Principal Investigators: Professors James Neil and Massimo Palmarini, University of Glasgow
    Award: 4.80 million
    Project title: Integrating Veterinary and Human Virology in the Centre for Virus Research

  • Principal Investigators: Professor Simon Duckett, University of York
    Award: 4.36 million
    Project title: Centre of Hyperpolarisation in Magnetic Resonance Imaging


'/>"/>

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
Source:Eurekalert

Related biology news :

1. New partnership offers outsourced R&D in membrane biology
2. UD hosts conference on knowledge-based partnerships Nov. 2
3. Elsevier announces new journal partnership for 2008
4. Emory, Ohio State launch partnership in predictive and personalized health care
5. United Water, in partnership with Stevens, wins Management Innovation Award
6. MIT, Eni announce energy research partnership
7. GM, Coskata partnership builds on Oklahoma State University biofuels research
8. Oak Ridge to lead auto supplier R&D partnership
9. Citizen Science -- a celebration of partnership between academia and local people
10. Cell Press announces new partnership with the Biophysical Society
11. KAUST announces academic excellence alliance partnership with Imperial College London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/20/2016)... 20, 2016  VoiceIt is excited to announce ... By working together, VoiceIt and VoicePass ... and VoicePass take slightly different approaches to voice ... security and usability. ... new partnership. "This marketing and technology ...
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: